Identification of ovarian cancer associated genes using an integrated approach in a Boolean framework

BMC Systems Biology

Volumn 7, Issue , 2013, Pages

  Kumar, Gaurav ^a,b   Breen, Edmond J ^a   Ranganathan, Shoba ^a,c  

^a MACQUARIE UNIVERSITY   (Australia)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BUB1 SPINDLE CHECKPOINT PROTEIN; CHECKPOINT KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BIOLOGICAL MODEL; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC MARKER; GENETICS; HUMAN; KAPLAN MEIER METHOD; METHODOLOGY; OVARY TUMOR; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR GENE;

DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; KAPLAN-MEIER ESTIMATE; MODELS, GENETIC; OVARIAN NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

MLCS; MLOWN;

EID: 84873256649     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-12     Document Type: Article

References (77)

1. Muller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH, et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008, 455(7211):401-405. 10.1038/nature07213, 2637443, 18724358.
2. Walker JR, Su AI, Self DW, Hogenesch JB, Lapp H, Maier R, Hoyer D, Bilbe G. Applications of a rat multiple tissue gene expression data set. Genome Res 2004, 14(4):742-749. 10.1101/gr.2161804, 383321, 15060018.
3. Magwene PM, Kim J. Estimating genomic coexpression networks using first-order conditional independence. Genome Biol 2004, 5(12):R100. 10.1186/gb-2004-5-12-r100, 545795, 15575966.
4. Kar G, Gursoy A, Keskin O. Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 2009, 5(12):e1000601. 10.1371/journal.pcbi.1000601, 2785480, 20011507.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100(1):57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
6. Wong DJ, Segal E, Chang HY. Stemness, cancer and cancer stem cells. Cell Cycle 2008, 7(23):3622-3624. 10.4161/cc.7.23.7104, 19029796.
7. Glinsky GV. " Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol 2008, 26(17):2846-2853. 10.1200/JCO.2008.17.0266, 18539963.
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
9. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, et al. NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res 2011, 39(Database issue):D1005-D1010. 3013736, 21097893.
10. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/nature04296, 16273092.
11. Zhang W, Laborde PM, Coombes KR, Berry DA, Hamilton SR. Cancer genomics: promises and complexities. Clin Cancer Res 2001, 7(8):2159-2167.
12. Mukherjee S, Pelech S, Neve RM, Kuo WL, Ziyad S, Spellman PT, Gray JW, Speed TP. Sparse combinatorial inference with an application in cancer biology. Bioinformatics 2009, 25(2):265-271. 10.1093/bioinformatics/btn611, 2639004, 19038985.
13. Kooperberg C, Ruczinski I. Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol 2005, 28(2):157-170. 10.1002/gepi.20042, 15532037.
14. Schwender H, Ruczinski I. Logic regression and its extensions. Adv Genet 2010, 72:25-45.
15. Nagaraj SH, Reverter A. A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer. BMC Syst Biol 2011, 5:35. 10.1186/1752-0509-5-35, 3051904, 21352556.
16. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69(1):138-147. 10.1086/321276, 1226028, 11404819.
17. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474(7353):609-615. 10.1038/nature10166, 3163504, 21720365, Cancer Genome Atlas Research Network.
18. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004, 573(1-3):83-92.
19. Lage K, Hansen NT, Karlberg EO, Eklund AC, Roque FS, Donahoe PK, Szallasi Z, Jensen TS, Brunak S. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA 2008, 105(52):20870-20875. 10.1073/pnas.0810772105, 2606902, 19104045.
20. Latchman DS. Transcription-factor mutations and disease. N Engl J Med 1996, 334(1):28-33. 10.1056/NEJM199601043340108, 7494569.
21. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005, 41(16):2462-2478. 10.1016/j.ejca.2005.08.013, 16213704.
22. Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JA, Williams C, Zhao C. Interplay between AP-1 and estrogen receptor alpha in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis 2012, 33(9):1684-1691. 10.1093/carcin/bgs223, 22791811.
23. Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics 2006, 5(10):1799-1810. 10.1074/mcp.R600009-MCP200, 16844681.
24. Anbalagan M, Huderson B, Murphy L, Rowan BG. Post-translational modifications of nuclear receptors and human disease. Nucl Recept Signal 2012, 10:e001. 3309075, 22438791.
25. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011, 39(Database issue):D945-D950. 3013785, 20952405.
26. Callesen AK, Mogensen O, Jensen AK, Kruse TA, Martinussen T, Jensen ON, Madsen JS. Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review. J Proteomics 2012, 75(10):2758-2772. 10.1016/j.jprot.2012.02.007, 22366292.
27. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst 2001, 93(19):1458-1464. 10.1093/jnci/93.19.1458, 11584061.
28. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002, 287(13):1671-1679. 10.1001/jama.287.13.1671, 11926891.
29. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin CH, Smoot M, Sahasrabudhe S, et al. A human MAP kinase interactome. Nat Methods 2010, 7(10):801-805. 10.1038/nmeth.1506, 2967489, 20936779.
30. Hatada I, Fukasawa M, Kimura M, Morita S, Yamada K, Yoshikawa T, Yamanaka S, Endo C, Sakurada A, Sato M, et al. Genome-wide profiling of promoter methylation in human. Oncogene 2006, 25(21):3059-3064. 10.1038/sj.onc.1209331, 16407832.
31. Huret JL, Dessen P, Bernheim A. Atlas of Genetics and Cytogenetics in Oncology and Haematology, year 2003. Nucleic Acids Res 2003, 31(1):272-274. 10.1093/nar/gkg126, 165573, 12520000.
32. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-183. 10.1038/nrc1299, 2665285, 14993899.
33. Prasad TS, Kandasamy K, Pandey A. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol 2009, 577:67-79. 10.1007/978-1-60761-232-2_6, 19718509.
34. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298(5600):1912-1934. 10.1126/science.1075762, 12471243.
35. Jiang C, Xuan Z, Zhao F, Zhang MQ. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007, 35(Database issue):D137-D140. 1899102, 17202159.
36. Chen YA, Tripathi LP, Mizuguchi K. TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery. PLoS One 2011, 6(3):e17844. 10.1371/journal.pone.0017844, 3050930, 21408081.
37. Mankoo PK, Shen R, Schultz N, Levine DA, Sander C. Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles. PLoS One 2011, 6(11):e24709. 10.1371/journal.pone.0024709, 3207809, 22073136.
38. Gilbert D. Biomolecular interaction network database. Brief Bioinform 2005, 6(2):194-198. 10.1093/bib/6.2.194, 15975228.
39. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, Nixon J, Van Auken K, Wang X, Shi X, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 2011, 39(Database issue):D698-D704. 3013707, 21071413.
40. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, Eisenberg D. The Database of Interacting Proteins: 2004 update. Nucleic Acids Res 2004, 32(Database issue):D449-D451. 308820, 14681454.
41. Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C, Dimmer E, Feuermann M, Friedrichsen A, Huntley R, et al. IntAct--open source resource for molecular interaction data. Nucleic Acids Res 2007, 35(Database issue):D561-D565. 1751531, 17145710.
42. Ceol A, Chatr Aryamontri A, Licata L, Peluso D, Briganti L, Perfetto L, Castagnoli L, Cesareni G. MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 2010, 38(Database issue):D532-D539. 2808973, 19897547.
43. Stein A, Ceol A, Aloy P. 3did: identification and classification of domain-based interactions of known three-dimensional structure. Nucleic Acids Res 2011, 39(Database issue):D718-D723. 3013799, 20965963.
44. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, et al. The Pfam protein families database. Nucleic Acids Res 2010, 38(Database issue):D211-D222. 2808889, 19920124.
45. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, Ceol A, Moore S, Orchard S, Sarkans U, von Mering C, et al. The HUPO PSI's molecular interaction format-a community standard for the representation of protein interaction data. Nat Biotechnol 2004, 22(2):177-183. 10.1038/nbt926, 14755292.
46. Patil A, Nakai K, Kinoshita K. Assessing the utility of gene co-expression stability in combination with correlation in the analysis of protein-protein interaction networks. BMC Genomics 2011, 12(Suppl 3):S19. 10.1186/1471-2164-12-S3-S19, 3333178, 22369639.
47. Chen R, Li L, Butte AJ. AILUN: reannotating gene expression data automatically. Nat Methods 2007, 4(11):879. 10.1038/nmeth1107-879, 2716375, 17971777.
48. Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, Yang S, Zhang S, Liu L, Lu M, O'Connor-McCourt M, et al. A map of human cancer signaling. Mol Syst Biol 2007, 3:152. 2174632, 18091723.
49. Csardi G, Nepusz T. The igraph software package for complex network research. InterJ Complex Syst 2006, 1695. http://igraph.sf.net 2013 Feb 4.
50. Papanikolaou V, Iliopoulos D, Dimou I, Dubos S, Kappas C, Kitsiou-Tzeli S, Tsezou A. Survivin regulation by HER2 through NF-kappaB and c-myc in irradiated breast cancer cells. J Cell Mol Med 2011, 15(7):1542-1550. 10.1111/j.1582-4934.2010.01149.x, 20716114.
51. Shiratsuchi I, Akagi Y, Kawahara A, Kinugasa T, Romeo K, Yoshida T, Ryu Y, Gotanda Y, Kage M, Shirouzu K. Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer. Anticancer Res 2011, 31(7):2541-2545.
52. Mejia W, Castro C, Umana A, de Castro C, Riveros T, Sanchez-Gomez M. [Insulin-like growth factor receptor I signaling in a breast cancer cell line]. Biomedica 2010, 30(4):551-558.
53. Jia SH, Parodo J, Kapus A, Rotstein OD, Marshall JC. Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8. J Biol Chem 2008, 283(9):5402-5413.
54. Kulkarni AA, Kingsbury SR, Tudzarova S, Hong HK, Loddo M, Rashid M, Rodriguez-Acebes S, Prevost AT, Ledermann JA, Stoeber K, et al. Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res 2009, 15(7):2417-2425. 10.1158/1078-0432.CCR-08-1276, 19318489.
55. Ricke RM, Jeganathan KB, van Deursen JM. Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J Cell Biol 2011, 193(6):1049-1064. 10.1083/jcb.201012035, 3115799, 21646403.
56. Thorsen K, Schepeler T, Oster B, Rasmussen MH, Vang S, Wang K, Hansen KQ, Lamy P, Pedersen JS, Eller A, et al. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis. BMC Genomics 2011, 12:505. 10.1186/1471-2164-12-505, 3208247, 21999571.
57. Hoglund A, Nilsson LM, Muralidharan SV, Hasvold LA, Merta P, Rudelius M, Nikolova V, Keller U, Nilsson JA. Therapeutic implications for the induced levels of chk1 in myc-expressing cancer cells. Clin Cancer Res 2011, 17(22):7067-7079. 10.1158/1078-0432.CCR-11-1198, 21933891.
58. Indra D, Mitra S, Singh RK, Dutta S, Roy A, Mondal RK, Basu PS, Roychoudhury S, Panda CK. Inactivation of CHEK1 and EI24 are associated with the development of invasive cervical carcinoma: Clinical and prognostic implications. Int J Cancer 2011, 129(8):1859-1871. 10.1002/ijc.25849, 21154811.
59. O'Mara TA, Ferguson K, Fahey P, Marquart L, Yang HP, Lissowska J, Chanock S, Garcia-Closas M, Thompson DJ, Healey CS, et al. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk. Twin Res Hum Genet 2011, 14(4):328-332. 10.1375/twin.14.4.328, 21787115.
60. Di Cera E. Serine proteases. IUBMB Life 2009, 61(5):510-515. 10.1002/iub.186, 2675663, 19180666.
61. Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci 2008, 65(7-8):1220-1236.
62. Rezze GG, Fregnani JH, Duprat J, Landman G. Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum Pathol 2011, 42(3):409-418. 10.1016/j.humpath.2010.09.004, 21193224.
63. Kim JT, Song EY, Chung KS, Kang MA, Kim JW, Kim SJ, Yeom YI, Kim JH, Kim KH, Lee HG. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 2011, 117(12):2608-2619. 10.1002/cncr.25841, 21656738.
64. Law AY, Wong CK. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res 2010, 316(20):3425-3434. 10.1016/j.yexcr.2010.06.026, 20619259.
65. Moretti RM, Mai S, Montagnani Marelli M, Rizzi F, Bettuzzi S, Limonta P. Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells. Int J Oncol 2011, 39(1):225-234.
66. Miyamoto T, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma. Exp Mol Pathol 2011, 91(2):563-568. 10.1016/j.yexmp.2011.06.002, 21763306.
67. Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O'Brien DI, Shah R, Syed N, Spender LC, Herrera B, et al. Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J Clin Invest 2010, 120(8):2842-2857. 10.1172/JCI36125, 2912175, 20592473.
68. Chen Y, Cui T, Knosel T, Yang L, Zoller K, Petersen I. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Lung Cancer 2011, 73(1):38-44. 10.1016/j.lungcan.2010.10.015, 21095038.
69. Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, Macarthur S, Stark R, Warren AY, Mills IG, et al. The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man. Cancer Cell 2012,
70. Lau KM, Mok SC, Ho SM. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 1999, 96(10):5722-5727. 10.1073/pnas.96.10.5722, 21927, 10318951.
71. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomics signatures. Bioinformatics 2006, 22(23):2926-33. 10.1093/bioinformatics/btl483, 17000751.
72. Stelzer G, Dalah I, Stein TI, Satanower Y, Rosen N, Nativ N, Oz-Levi D, Olender T, Belinky F, Bahir I, Krug H, Perco P, Mayer B, Kolker E, Safran M, Lancet D. In-silico human genomics with GeneCards. Hum Genomics 2011, 5(6):709-17. 3525253, 22155609.
73. Liekens AM, De Knijf J, Daelemans W, Goethals B, De Rijk P, Del-Favero J. BioGraph: unsupervised biomedical knowledge discovery via automated hypothesis generation. Genome Biol 2011, 12(6):R57. 10.1186/gb-2011-12-6-r57, 3218845, 21696594.
74. Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 2010, 16(2):376-383. 10.1158/1078-0432.CCR-09-1029, 2939735, 20068082.
75. Nodin B, Zendehrokh N, Brändstedt J, Nilsson E, Manjer J, Brennan DJ, Jirström K. Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival. J Ovarian Res. 2010, 3:14. 10.1186/1757-2215-3-14, 2902477, 20565760.
76. Zhang S, Liu CC, Li W, Shen H, Laird PW, Zhou XJ. Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res 2012, 40(19):9379-9391. 10.1093/nar/gks725, 3479191, 22879375.
77. Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O'Connor-McCourt MD, Wang E. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun 2010, 1:34. 2972666, 20975711.